Uterine Cancer Survival Rate (Cont.)

Factors Affecting the Uterine Cancer Survival Rate

In general, the uterine cancer survival rate will depend on:
 
  • The stage of uterine cancer (whether it is in the endometrium only, involves the whole uterus, or has spread to other places in the body)
  • How the uterine cancer cells look under a microscope
  • Whether the cancer cells are affected by progesterone
  • Whether the cancer has just been diagnosed or has come back.
 
It is important to note that uterine cancer is highly curable.
 

Overall Uterine Cancer Survival Rates

Survival rates can be calculated by different methods for different purposes. The uterine cancer survival rates presented here are based on the relative survival rate. The relative survival rate measures the survival of the cancer patients in comparison to the general population to estimate the effect of the cancer. The overall 5-year relative uterine cancer survival rate for 1995-2001 was 84.4 percent. The 5-year relative uterine cancer survival rates by race were:
 
  • 86.2 percent for Caucasian women
  • 61.8 percent for African American women.
 

Uterine Cancer Survival Rates: Based on Stage

The uterine cancer stage plays a role in the uterine cancer prognosis. Based on historical data:
 
  • 72 percent of uterine cases are diagnosed while the cancer is still confined to the primary site (localized stage)
 
  • 16 percent of uterine cancer cases are diagnosed after the cancer has spread to regional lymph nodes or directly beyond the primary site
 
  • 8 percent of uterine cancer cases are diagnosed after the cancer has already metastasized (distant stage)
 
  • 4 percent of uterine cancer cases had staging information that was unknown.
 
The corresponding 5-year relative uterine cancer survival rates were:
 
  • 96.1 percent for localized
  • 66.3 percent for regional
  • 25.2 percent for distant
  • 57.3 percent for unstaged.
 
(Click Uterine Cancer Statistics for more statistics on uterine cancer.)
Pages:

Previous 1   2

Written by/reviewed by: Arthur Schoenstadt, MD
Last reviewed by: Arthur Schoenstadt, MD